Clinical Trial Update: Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating immunotherapy with irreversible electroporation for advanced pancreatic adenocarcinoma. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: University of Louisville | Conditions: Pancreatic Adenocarcinoma | Phase 2 | Status: RECRUITING